Institutional investors hold a majority ownership of ABMD through the 108.70% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended March 2014, these large investors purchased a net $3.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APEX CAPITAL MANAGEMENT, INC. Bought 19.3 Thousand shares of Abiomed Inc